Stock 1134 KELFRED HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Kelfred Holdings Limited

Equities

1134

KYG5S44A1075

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:39 2024-05-28 am EDT 		5-day change 1st Jan Change
0.4 HKD 0.00% Intraday chart for Kelfred Holdings Limited -3.61% -11.11%
Mar. 26 Kelfred Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 15 Kelfred Holdings Limited Provides Preliminary Unaudited Consolidated Group Earnings Guidance for the Year Ended 31 December 2023 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023
Capitalization 1 460 1,630 615 345 225
Enterprise Value (EV) 1 397.8 1,567 582.1 300.6 219.9
P/E ratio 47.5 x -122 x -287 x 37.6 x 162 x
Yield 2.17% - - - -
Capitalization / Revenue 1.11 x 4.6 x 1.41 x 0.74 x 0.57 x
EV / Revenue 0.96 x 4.42 x 1.34 x 0.65 x 0.56 x
EV / EBITDA 11.4 x 462 x 46.3 x 21 x -34.6 x
EV / FCF -1,100 x 65 x -21 x 20.4 x -7.56 x
FCF Yield -0.09% 1.54% -4.76% 4.89% -13.2%
Price to Book 2.22 x 8.8 x 3.3 x 1.85 x 1.23 x
Nbr of stocks (in thousands) 500,000 500,000 500,000 500,000 500,000
Reference price 2 0.9200 3.260 1.230 0.6900 0.4500
Announcement Date 4/20/20 4/28/21 4/28/22 4/28/23 4/29/24
1HKD in Million2HKD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 421.1 413.4 354.2 434.7 465.4 393.3
EBITDA 1 53.34 34.92 3.39 12.57 14.3 -6.348
EBIT 1 43.54 25.17 -7.373 1.431 7.461 -12.99
Operating Margin 10.34% 6.09% -2.08% 0.33% 1.6% -3.3%
Earnings before Tax (EBT) 1 38.37 13.74 -12.19 -1.587 10.68 2.178
Net income 1 30.42 8.377 -13.4 -2.14 9.183 1.388
Net margin 7.22% 2.03% -3.78% -0.49% 1.97% 0.35%
EPS 2 0.0811 0.0194 -0.0268 -0.004280 0.0184 0.002776
Free Cash Flow 1 52.88 -0.3618 24.1 -27.72 14.7 -29.08
FCF margin 12.56% -0.09% 6.81% -6.38% 3.16% -7.39%
FCF Conversion (EBITDA) 99.15% - 711.02% - 102.82% -
FCF Conversion (Net income) 173.84% - - - 160.1% -
Dividend per Share - 0.0200 - - - -
Announcement Date 6/28/19 4/20/20 4/28/21 4/28/22 4/28/23 4/29/24
1HKD in Million2HKD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 27.2 - - - - -
Net Cash position 1 - 62.2 62.9 32.9 44.4 5.12
Leverage (Debt/EBITDA) 0.5107 x - - - - -
Free Cash Flow 1 52.9 -0.36 24.1 -27.7 14.7 -29.1
ROE (net income / shareholders' equity) 25.3% 5.96% -6.87% -1.15% 4.93% 0.75%
ROA (Net income/ Total Assets) 11.5% 5.99% -1.54% 0.32% 1.79% -3.15%
Assets 1 265.1 139.9 868.8 -664.4 512 -44.1
Book Value Per Share 2 0.2600 0.4100 0.3700 0.3700 0.3700 0.3700
Cash Flow per Share 2 0.0500 0.1700 0.1500 0.0700 0.0900 0.0400
Capex 1 4.79 7.93 4.99 5.14 4.69 15.7
Capex / Sales 1.14% 1.92% 1.41% 1.18% 1.01% 3.99%
Announcement Date 6/28/19 4/20/20 4/28/21 4/28/22 4/28/23 4/29/24
1HKD in Million2HKD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Glasses, Spectacles & Contact Lenses

1st Jan change Capi.
KELFRED HOLDINGS LIMITED Stock Kelfred Holdings Limited
-11.11% 25.62M
ALCON INC. Stock Alcon Inc.
+23.19% 44.52B
THE COOPER COMPANIES, INC. Stock The Cooper Companies, Inc.
-3.10% 18.86B
AUTEK CHINA INC. Stock Autek China Inc.
-20.15% 2.25B
WARBY PARKER INC. Stock Warby Parker Inc.
+21.56% 2.05B
PEGAVISION CORPORATION Stock Pegavision Corporation
+18.16% 1.15B
MINGYUE OPTICAL LENS CO.,LTD. Stock Mingyue Optical Lens Co.,Ltd.
-38.08% 730M
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD. Stock Universal Vision Biotechnology Co., Ltd.
-7.94% 675M
MENICON CO., LTD. Stock Menicon Co., Ltd.
-43.36% 645M
SHANGHAI CONANT OPTICAL CO., LTD. Stock Shanghai Conant Optical Co., Ltd.
+43.63% 538M
Glasses, Spectacles & Contact Lenses
  1. Stock Market
  2. Equities
  3. 1134 Stock
  4. Financials Kelfred Holdings Limited